RNXT
RNXT
NASDAQ · Biotechnology

Renovorx Inc

$0.99
+0.04 (+4.11%)
As of Feb 8, 2:21 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.79M 3.81M 2.96M
Net Income 783.4K 928.9K 608.3K
EPS
Profit Margin 20.7% 24.4% 20.5%
Rev Growth +6.9% +13.5% +17.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 13.03M 11.58M 13.18M
Total Equity 14.21M 15.57M 13.44M
D/E Ratio 0.92 0.74 0.98
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.80M 1.92M 1.50M
Free Cash Flow 820.9K 949.0K 713.4K